Cargando…
TCF7 knockdown inhibits the imatinib resistance of chronic myeloid leukemia K562/G01 cells by neutralizing the Wnt/β-catenin/TCF7/ABC transporter signaling axis
Clinical resistance to ABL tyrosine kinase inhibitor (TKI) imatinib remains a critical issue in the treatment of chronic myeloid leukemia (CML). Transcription factor 7 (TCF7) is one of the main Wnt/β-catenin signaling mediators. Previous studies have shown that TCF7 is vital for tumor initiation, an...
Autores principales: | Zhang, Hui, Wang, Yonghong, Yang, Hao, Huang, Zhenglan, Wang, Xin, Feng, Wenli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7757089/ https://www.ncbi.nlm.nih.gov/pubmed/33416164 http://dx.doi.org/10.3892/or.2020.7869 |
Ejemplares similares
-
lncTCF7 is a negative prognostic factor, and knockdown of lncTCF7 inhibits migration, proliferation and tumorigenicity in glioma
por: Gao, Xiao, et al.
Publicado: (2017) -
abc TCF : test de connaissance du français : 200 activités /
por: Mégre, Bruno
Publicado: (2014) -
RNF2 regulates Wnt/ß-catenin signaling via TCF7L1 destabilization
por: Koo, Youngmu, et al.
Publicado: (2023) -
Wnt/β‐catenin signaling in brain development and mental disorders: keeping TCF7L2 in mind
por: Bem, Joanna, et al.
Publicado: (2019) -
NOP7 interacts with β-catenin and activates β-catenin/TCF signaling in hepatocellular carcinoma cells
por: Wu, Nan, et al.
Publicado: (2018)